A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

Clinical Trial ID NCT00503984

PubWeight™ 8.78^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00503984

Top papers